Zobrazeno 1 - 10
of 16 652
pro vyhledávání: '"Kidney cancer"'
Publikováno v:
Research and Reports in Urology, Vol Volume 16, Pp 161-176 (2024)
Jonathan Chatzkel,1 Mayer Fishman,2 Brian Ramnaraign,1 Padraic O’Malley,3 Guru P Sonpavde4 1Division of Hematology and Oncology, Department of Medicine, University of Florida, Gainesville, FL, USA; 2University of South Florida, Tampa, FL, USA; 3Dep
Externí odkaz:
https://doaj.org/article/efdf88de76e94c728820ea463707abd0
Autor:
Elin Sjöberg
Publikováno v:
Upsala Journal of Medical Sciences, Vol 129, Pp 1-8 (2024)
Background: Clear cell renal cell carcinoma (ccRCC) is the most common renal cancer in adults and stands out as one of the most vascularized and immune-infiltrated solid tumors. Overproduction of vascular endothelial growth factor A promotes uncontro
Externí odkaz:
https://doaj.org/article/725c5f6c185c43209fdf64934d99ce1e
Publikováno v:
Current Issues in Molecular Biology, Vol 46, Iss 5, Pp 4595-4608 (2024)
Proteogenomics represents a transformative intersection in nephrology, uniting genomics, transcriptomics, and proteomics to unravel the molecular intricacies of kidney diseases. This review encapsulates the methodological essence of proteogenomics an
Externí odkaz:
https://doaj.org/article/9dc3879765cb4de0b3344948f1102648
Autor:
Konrad Grützmann, Karsten Salomo, Alexander Krüger, Andrea Lohse-Fischer, Kati Erdmann, Michael Seifert, Gustavo Baretton, Daniela Aust, Doreen William, Evelin Schröck, Christian Thomas, Susanne Füssel
Publikováno v:
Biology Direct, Vol 19, Iss 1, Pp 1-15 (2024)
Abstract Background Clear cell renal cell carcinoma (ccRCC) is the most common subtype of RCC with high rates of metastasis. Targeted therapies such as tyrosine kinase and checkpoint inhibitors have improved treatment success, but therapy-related sid
Externí odkaz:
https://doaj.org/article/01f8ed8b79a74027a6c7059899fbf7ed
Autor:
Thorri Geir Runarsson, Andreas Bergmann, Gigja Erlingsdottir, Vigdis Petursdottir, Leon Arnar Heitmann, Aevar Johannesson, Viktor Asbjornsson, Tomas Axelsson, Rafn Hilmarsson, Tomas Gudbjartsson
Publikováno v:
BMC Urology, Vol 24, Iss 1, Pp 1-11 (2024)
Abstract Introduction Papillary renal cell carcinoma (pRCC) is the second most common histology of renal cell carcinoma (RCC), accounting for 10–15% of cases. Traditionally, pRCC is divided into type 1 and type 2, although this division is currentl
Externí odkaz:
https://doaj.org/article/d63c25f2fa0f4684b3ba65f8cea34926
Publikováno v:
Scientific Reports, Vol 14, Iss 1, Pp 1-10 (2024)
Abstract The kidney cancer (KC) burden measures have changed dramatically in recent years due to changes in exposure to the determinants over time. We aimed to decompose the difference in the KC burden measures between 1990 and 2019. This ecological
Externí odkaz:
https://doaj.org/article/dc37aed1cb504810b8882232637931a2
Publikováno v:
Cancer Cell International, Vol 24, Iss 1, Pp 1-13 (2024)
Abstract Background Cell division cycle associated 5 (CDCA5) plays ontogenetic role in various human cancers. However, its specific function and regulatory mechanism in ccRCC remain uncertain. Methods Immunohistochemistry and western blots were perfo
Externí odkaz:
https://doaj.org/article/ccd41226b512467a93765f7eeade1c98
Publikováno v:
Current Issues in Molecular Biology, Vol 46, Iss 4, Pp 3236-3250 (2024)
Radiogenomics, a burgeoning field in biomedical research, explores the correlation between imaging features and genomic data, aiming to link macroscopic manifestations with molecular characteristics. In this review, we examine existing radiogenomics
Externí odkaz:
https://doaj.org/article/7bfd5dcc57314eb6b260eb575047e010
Autor:
Safia Iqbal, Md. Rezaul Karim, Shahnawaz Mohammad, Jong Chan Ahn, Anjali Kariyarath Valappil, Ramya Mathiyalagan, Deok-Chun Yang, Dae-Hyo Jung, Hyocheol Bae, Dong Uk Yang
Publikováno v:
Current Issues in Molecular Biology, Vol 46, Iss 4, Pp 3328-3341 (2024)
Kidney cancer has emerged as a major medical problem in recent times. Multiple compounds are used to treat kidney cancer by triggering cancer-causing gene targets. For instance, isoquercitrin (quercetin-3-O-β-d-glucopyranoside) is frequently present
Externí odkaz:
https://doaj.org/article/15625d8b73324a5a94066afd7e655f33
Publikováno v:
Current Oncology, Vol 31, Iss 4, Pp 2316-2327 (2024)
The treatment landscape of genitourinary cancers has significantly evolved over the past few years. Renal cell carcinoma, bladder cancer, and prostate cancer are the most common genitourinary malignancies. Recent advancements have produced new target
Externí odkaz:
https://doaj.org/article/ec64be202f9c4c46a2a722bdc81927b3